Effect of caffeine on bladder function in patients with overactive bladder symptoms
- PMID: 21346827
- PMCID: PMC3036994
- DOI: 10.4103/0974-7796.75862
Effect of caffeine on bladder function in patients with overactive bladder symptoms
Abstract
Objectives: To evaluate the effect of caffeine at the dose of 4.5 mg/kg on bladder function in overactive bladder (OAB) adults.
Materials and methods: Nine women and three men aged 21-40 years with OAB symptoms were included. Each subject drank 8 ml/kg of water with and without caffeine at two separate sessions. Cystometry and uroflowmetry were performed 30 minutes after each drink. The effects of caffeine on urodynamic parameters were compared.
Results: After caffeine ingestion, the mean volume at bladder filling phase decreased at first desire to void and normal desire to void (P<0.05), compared to the mean volume after taking water (control) drink. The mean volume at strong desire to void, urgency and maximum cystometric capacity also tended to decrease. No change in the detrusor pressure at filling phase was found. At voiding phase, the maximal flow rate, average flow rate and voided volume were increased (P<0.05). The urine flow time and time to maximal flow rate were not changed.
Conclusion: Caffeine at 4.5 mg/kg caused diuresis and decreased the threshold of sensation at filling phase, with an increase in flow rate and voided volume. So, caffeine can promote early urgency and frequency of urination. Individuals with lower urinary tract symptom should avoid or be cautious in consuming caffeine containing foodstuffs.
Keywords: Caffeine; overactive bladder; uroflowmetry.
Conflict of interest statement
Figures



Similar articles
-
Urodynamic evaluation of the efficacy of mirabegron on storage and voiding functions in women with overactive bladder.Urology. 2015 Apr;85(4):786-90. doi: 10.1016/j.urology.2015.01.002. Epub 2015 Feb 20. Urology. 2015. PMID: 25709050 Clinical Trial.
-
[Recommendations for the urodynamic examination in the investigation of non-neurological female urinary incontinence].Prog Urol. 2007 Nov;17(6 Suppl 2):1264-84. Prog Urol. 2007. PMID: 18214138 Review. French.
-
Associations between subjective overactive bladder symptoms and objective parameters on bladder diary and filling cystometry.Int Urogynecol J. 2012 Nov;23(11):1619-24. doi: 10.1007/s00192-012-1774-3. Epub 2012 Apr 28. Int Urogynecol J. 2012. PMID: 22543547 Free PMC article.
-
Urodynamic Efficacy and Safety of Mirabegron Add-on Treatment with Tamsulosin for Japanese Male Patients with Overactive Bladder.Low Urin Tract Symptoms. 2016 Sep;8(3):171-6. doi: 10.1111/luts.12091. Epub 2015 Feb 17. Low Urin Tract Symptoms. 2016. PMID: 27619782
-
Defining overactive bladder as hypersensitivity.Neurourol Urodyn. 2007 Oct;26(6 Suppl):904-7. doi: 10.1002/nau.20482. Neurourol Urodyn. 2007. PMID: 17663416 Review.
Cited by
-
Caffeine as a Factor Influencing the Functioning of the Human Body-Friend or Foe?Nutrients. 2021 Sep 2;13(9):3088. doi: 10.3390/nu13093088. Nutrients. 2021. PMID: 34578966 Free PMC article. Review.
-
A healthy bladder: a consensus statement.Int J Clin Pract. 2011 Oct;65(10):1026-36. doi: 10.1111/j.1742-1241.2011.02763.x. Int J Clin Pract. 2011. PMID: 21923844 Free PMC article.
-
Overactive Bladder Syndrome: Evaluation and Management.Curr Urol. 2018 Mar;11(3):117-125. doi: 10.1159/000447205. Epub 2018 Feb 20. Curr Urol. 2018. PMID: 29692690 Free PMC article. Review.
-
Increased fluid intake is associated with bothersome bowel symptoms among women with urinary incontinence.Female Pelvic Med Reconstr Surg. 2013 May-Jun;19(3):152-6. doi: 10.1097/SPV.0b013e318288ac08. Female Pelvic Med Reconstr Surg. 2013. PMID: 23611933 Free PMC article.
-
Barriers and facilitators to overactive bladder therapy adherence.Neurourol Urodyn. 2022 Nov;41(8):1983-1992. doi: 10.1002/nau.24936. Epub 2022 May 5. Neurourol Urodyn. 2022. PMID: 35510540 Free PMC article. Review.
References
-
- Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology in lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61:37–49. - PubMed
-
- Tubaro A. Defining overactive bladder: Epidemiology and burden of disease. Urology. 2004;64:2–6. - PubMed
-
- Freeman RM, Adekanmi OA. Overactive bladder. Best Pract Res Clin Obstet Gynaecol. 2005;19:829–41. - PubMed
-
- Sussman DO. Overactive bladder: Treatment options in primary care medicine. J Am Osteopath Assoc. 2007;107:379–86. - PubMed
-
- Liao YM, Dougherty MC, Biemer PP, Liao CT, Palmer MH, Boyington AR, et al. Factors related to lower urinary tract symptoms among a sample of employed women in Taipei. Neurourol Urodyn. 2008;27:52–9. - PubMed